Skip to main content
. 2020 Sep 6;19(7):1410–1417.e9. doi: 10.1016/j.cgh.2020.09.008

Figure 1.

Figure 1

Illustrative description of the rationale: SARS-Cov-2 effects on screening programs and consequently on the CRC stage distribution and survival rates. CRC, colorectal cancer; FIT, fecal immunochemical test; SARS-Cov-2, severe acute respiratory distress syndrome–associated coronavirus 2.